 More than a decade later genomics is still big in business (and big business): the Obama administration announced in January 2015 that they intend to sequence one million human genomes (see Precision Medicine Initiative in the   Other Internet Resources section  below; see also Reardon 2015). Craig Venter, the commercially minded nemesis of the publicly-funded HGP is also in the mix again, this time involved in a privately-funded collaboration that aims to sequence two million genomes over the course of the next ten years (Ledford 2016). And equally important, we see not only the same players clash again but also the same promises being made, with talk of “groundbreaking health benefits” and “new medical breakthroughs” appearing once again in press releases and other announcements (see for instance Collins &amp; Varmus 2015 or NIH 2015).